FeesSafety
Pluang+

Bloom Energy faces class action lawsuit over alleged misleading statements causing investor losses.

Market News
31 Jul 2026
GlobeNewsWire
View Source
Bearish
Bloom Energy faces class action lawsuit over alleged misleading statements causing investor losses.

A shareholder has filed a class action lawsuit against Bloom Energy Corporation for allegedly making false and misleading statements about its business and financial health between February 2025 and July 2026. The lawsuit claims these misrepresentations artificially inflated the company's stock price, causing investors to suffer significant losses when the truth emerged. Investors who purchased Bloom Energy securities during this period are encouraged to contact Bernstein Liebhard LLP to discuss their rights and potentially join the lawsuit. The deadline to file to become lead plaintiff is September 28, 2026.

More News

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-led cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to enhance precision oncology research in Australia by linking cancer patients to biomarker-matched clinical trials. This collaboration combines Fortrea's oncology trial expertise with Omico's Prec...

Market News
Bullish
46 minutes ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to accelerate precision oncology research in Australia by connecting cancer patients to biomarker-driven clinical trials. The collaboration combines Fortrea's expertise in oncology clinical tri...

Market News
Bullish
46 minutes ago
Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea and Omico partner to speed biomarker-based cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research in Australia by combining Fortrea's clinical trial expertise with Omico's Precision Oncology Screening Platform (PrOSPeCT). This collaboration aims to impr...

Market News
Bullish
46 minutes ago
Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to accelerate biomarker-driven cancer drug trials in Australia

Fortrea Holdings Inc and Omico have formed a partnership to enhance precision oncology research in Australia by matching cancer patients with biomarker-driven clinical trials. This collaboration combines Fortrea's expertise in oncology clinical trial...

Market News
Bullish
46 minutes ago
Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea and Omico partner to enhance biomarker-driven cancer drug trials in Australia

Fortrea Holdings and Omico have formed a partnership to accelerate precision oncology research by improving biomarker-based clinical trial planning and patient recruitment in Australia. The collaboration leverages Fortrea's clinical trial expertise a...

Market News
Bullish
46 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App